12:33 O05 In vitro testing of the anticoagulant capacity of rivaroxaban according to severity of liver disease – Jill Vercruyssen

Belgium
  • 1

    Oral presentations Clinical and Laboratory

    Date: 28 Nov 2024Time: 11:45 - 12:45 CET